Search

everythinglearnresearchcommunity

for

Search:↓

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Women with female pattern hair loss have lower Vitamin D3 levels.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Many women with hard-to-treat acne also have PCOS.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Acne significantly affects both physical health and mental well-being.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.